SCG5 and Other metabolic disease: A limitation of our study design is that SNP tagging was based on data from HapMap phase I. According to HapMap phase II data [20] genotypes from 18 additional TagSNPs would be necessary for an extensive genetic coverage and comprehensive association analyses of SGNE1 with metabolic diseases.